What happened in optometry this week: August 26 - August 30
Catch up on what happened in optometry during the week of August 26-August 30.
Catch up with what Optometry Times shared this week:
You and Eye: Tips & tricks for streamlined pediatric eye exams - with Damaris Raymondi, OD, FAAO
By Miriam Korik, OD; Emily Kaiser Maharjan, Assistant Managing Editor; and Damaris Raymondi, OD, FAAO
It's time for back-to-school eye exams, and host Miriam Korik, OD, teams up with Eyes Up host Damaris Raymondi, OD, FAAO, to chat about how to handle pediatric eye exams efficiently, thoroughly, and confidently.
Strabismus and athletic performance with Dr. Brian Lojka
By Jordana Joy, Associate Editor, and Brian Lojka, OD
With Olympic gymnast Stephen Nedoroscik taking to the podium earlier this month at the 2024 Olympic Games in Paris, France, strabismus also garnered some airtime. Brian Lojka, OD, division medical officer for optometry at EyeCare Partners, sat down with Optometry Times to chat about the condition and what optometrists should keep in mind regarding care for athletes with eye conditions.
Ohio tackles pediatric eye health initiatives with Children’s Vision Strike Force
By Jordana Joy, Associate Editor
The state of Ohio, much like the rest of the country, is facing a pediatric eye care problem. Although several nonprofit organizations and government-funded programs and initiatives are working to ensure children’s eyes are examined, the fight continues to keep these examinations regular and consistent with a given patient’s needs in the state. However, these initiatives may see statewide regulation and growth thanks to a formative visit to southeastern Ohio made by Governor Mike DeWine.
Injectsense announces first human implant of ultraminiature IOP sensor
By Jordana Joy, Associate Editor
Digital health company Injectsense announced that it has successfully completed the first human implant and wireless IOP measurements using its ultraminiature implantable sensor, which has received FDA breakthrough designation.1 The implant procedure was performed during the IOP-Connect system study by Juan Mura, MD, of the Centro de la Vision in Santiago, Chile, according to a news release.
Using an anecdotal case study to lay old habits to rest
By Benjamin P. Casella, OD, FAAO
Old habits die hard. Such an adage is true from a clinical perspective. In terms of retinal vascular disease, I’d say we are likely going to be reliant on fluorescein angiography for the near future. However, there will come a day when injecting dye into a patient’s arm and taking subsequent sequences of fundus photos to diagnose a disease, stage a disease state, or monitor a patient’s response to treatment will no longer be necessary. That day will come, and countless clinicians will continue fluorescein angiography studies well past their date of obsolescence. From an ocular surface disease perspective, we are already well beyond the point of, “Here’s a bottle of whatever artificial tears I have a sample of; see you when your vision benefit will pay for another eye exam.”
